March 19, 2020
With updates occurring every day regarding COVID-19 impact on businesses, we wanted to reach out concerning SafeBridge operations specifically. First and foremost, we are reiterating our company's hope that you are staying safe and remain healthy. We know that you depend on SafeBridge to be responsive to your business challenges and ongoing work. We will update this page as new information becomes available, so please check periodically.
The SafeBridge team continues to operate in all aspects of our business but are following the limitations recommended and, in some cases, mandated by local, state, and national authorities. As a service provider to the pharma/biotech industry, which is considered an “essential business,” our laboratory is still accepting analytical work for business critical and “rush” industrial hygiene samples. However, employees and lab personnel who can work from home are being allowed to do so.
While we remain open for business, we are taking the following steps to protect our staff and to support you, our client:
Health Considerations for Our Employees - We continue to follow guidance and align our procedures with the CDC, WHO, and relevant government authorities. We are limiting our employees to only essential travel and laboratory work. Our policy and requests for travel are being reviewed daily.
Flexible Work Arrangements - Where not required by law, we are enabling our staff to work from home for anyone who needs this flexibility. Our technology and collaboration tools allow us to effectively continue to serve our clients.
Proactive Communication - We are in regular communication with our staff and our clients as we continue to adapt, protect, and maintain our services in the evolving conditions.
Continued Services - We are committed to providing the following ongoing services from our core and expanded teams.
For further information, or if you have questions, please contact either of us or your SafeBridge contact.
Stay safe and remain healthy!!
Allan Ader, Ph.D., DABT
Robert Sussman, Ph.D., DABT